Regorafenib Versus Placebo to Treat Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:July 31, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):CholangiocarcinomaLast Updated:July 31, 2020Unknown status
Condition(s):Cholangiocarcinoma; Klatskin Tumor; Bile Duct Cancer; Liver CancerLast Updated:December 19, 2023Not yet recruiting
Condition(s):Liver Cancer; Liver Tumor; Hepatocellular Carcinoma; Hilar CholangiocarcinomaLast Updated:November 13, 2018Enrolling by invitation
Condition(s):Bile Duct Stricture; Bile Duct CancerLast Updated:December 27, 2018Unknown status
Condition(s):Hilar Cholangiocarcinoma; Bile Duct Injury; Choledochal Cyst; Biliary CalculiLast Updated:September 21, 2017Unknown status
Condition(s):Hepatocellular Carcinoma; Hilar Cholangiocarcinoma; Intra Hepatic Cholangiocarcinoma; Liver MetastasisLast Updated:February 6, 2017Unknown status
Condition(s):Biliary Obstructive Disease Such as Choledocholithiasis; Benign Biliary Stricture; Peri-ampullary Cancer; Bile Duct Cancer Resectable; Klatskin TumorLast Updated:January 16, 2019Unknown status
Condition(s):Cholangiocarcinoma; Hepatobiliary Neoplasm; Liver Cancer; Bile Duct Cancer; Cancer of GallbladderLast Updated:July 29, 2016Terminated
Condition(s):Advanced Biliary Tract CancerLast Updated:June 23, 2023Completed
Condition(s):Hepatocellular Carcinoma; Obstructive JaundiceLast Updated:November 20, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.